158 related articles for article (PubMed ID: 19169862)
41. Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: a randomized clinical trial.
Entezari M; Ramezani A; Ahmadieh H; Bakhtiari P; Yaseri M; Soltani K
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):13-9. PubMed ID: 19779730
[TBL] [Abstract][Full Text] [Related]
42. [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
Bouchard O; Zech JC; Trepsat C
J Fr Ophtalmol; 1997; 20(4):263-70. PubMed ID: 9181137
[TBL] [Abstract][Full Text] [Related]
43. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy.
Sato T; Tsuboi K; Nakashima H; Emi K
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):665-671. PubMed ID: 27770210
[TBL] [Abstract][Full Text] [Related]
44. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
[No Abstract] [Full Text] [Related]
45. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
Chaudhry NA; Lim ES; Saito Y; Mieler WF; Liggett PE; Filatov V
Ophthalmology; 1995 Aug; 102(8):1164-9. PubMed ID: 9097742
[TBL] [Abstract][Full Text] [Related]
46. [Pre-basal vitreous body after subtotal vitrectomy of aphakic eyes].
Slezak H; Arocker-Mettinger E
Klin Monbl Augenheilkd; 1990 Aug; 197(2):110-1. PubMed ID: 2243468
[TBL] [Abstract][Full Text] [Related]
47. Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy.
Takamura Y; Shimura M; Katome T; Someya H; Sugimoto M; Hirano T; Sakamoto T; Gozawa M; Matsumura T; Inatani M;
Br J Ophthalmol; 2018 Oct; 102(10):1351-1357. PubMed ID: 29343528
[TBL] [Abstract][Full Text] [Related]
48. [Pars plana vitrectomy, phacoemulsification and intraocular lens implantation for the management of cataract and proliferative diabetic retinopathy: comparison of a combined versus two-step surgical approach].
Rivas-Aguiño P; García-Amaris RA; Berrocal MH; Sánchez JG; Rivas A; Arévalo JF
Arch Soc Esp Oftalmol; 2009 Jan; 84(1):31-8. PubMed ID: 19173136
[TBL] [Abstract][Full Text] [Related]
49. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
50. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
[TBL] [Abstract][Full Text] [Related]
51. [Treatment of vitreous hemorrhages. Spontaneous hemorrhages].
Ruellan YM
Bull Soc Ophtalmol Fr; 1987 Nov; Spec No():41-48, 51-8, 61-8 passim. PubMed ID: 2448052
[No Abstract] [Full Text] [Related]
52. Visual outcomes and complications after multiple vitrectomies for diabetic vitreous hemorrhage.
Cooper B; Shah GK; Grand MG; Bakal J; Sharma S
Retina; 2004 Feb; 24(1):19-22. PubMed ID: 15076939
[TBL] [Abstract][Full Text] [Related]
53. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
54. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
[TBL] [Abstract][Full Text] [Related]
55. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
Takayama K; Someya H; Yokoyama H; Kimura T; Takamura Y; Morioka M; Sameshima S; Ueda T; Ogata N; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Acta Ophthalmol; 2020 Jun; 98(4):e434-e439. PubMed ID: 31674137
[TBL] [Abstract][Full Text] [Related]
57. Incidence of rhegmatogenous retinal detachment after vitrectomy in eyes of diabetic patients.
Schrey S; Krepler K; Wedrich A
Retina; 2006 Feb; 26(2):149-52. PubMed ID: 16467669
[TBL] [Abstract][Full Text] [Related]
58. Entry site treatment to prevent late recurrent postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Steel DH; Connor A; Habib MS; Owen R
Br J Ophthalmol; 2010 Sep; 94(9):1219-25. PubMed ID: 19955203
[TBL] [Abstract][Full Text] [Related]
59. [Vitrectomy in proliferative diabetic retinopathy. Preoperative factors for surgical procedure and postoperative results].
Ulbig M; Kampik A; Heidenkummer HP
Fortschr Ophthalmol; 1990; 87(5):443-8. PubMed ID: 2272571
[TBL] [Abstract][Full Text] [Related]
60. 25-Gauge sutureless vitrectomy versus 20-gauge vitrectomy for the repair of primary rhegmatogenous retinal detachment.
Von Fricken MA; Kunjukunju N; Weber C; Ko G
Retina; 2009 Apr; 29(4):444-50. PubMed ID: 19174723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
